Details for New Drug Application (NDA): 004056
✉ Email this page to a colleague
NDA 004056 describes STILBETIN, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the STILBETIN profile page.
The generic ingredient in STILBETIN is diethylstilbestrol. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol profile page.
The generic ingredient in STILBETIN is diethylstilbestrol. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol profile page.
Summary for 004056
| Tradename: | STILBETIN |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | diethylstilbestrol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 004056
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;VAGINAL | Strength | 0.1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;VAGINAL | Strength | 0.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.2MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
